<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />



<meta name="date" content="2026-02-13" />

<title>IKS</title>

<script src="rmdlib/header-attrs-2.30/header-attrs.js"></script>
<script src="rmdlib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="rmdlib/bootstrap-3.3.5/css/flatly.min.css" rel="stylesheet" />
<script src="rmdlib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="rmdlib/navigation-1.1/tabsets.js"></script>
<script src="rmdlib/accessible-code-block-0.0.1/empty-anchor.js"></script>
<link href="rmdlib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="rmdlib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<meta name="description" content="Indian equities analysis, margin reports, risk, etc..." />
<meta property="og:image" content="https://avatars3.githubusercontent.com/u/21966469?s=400&v=4" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>










<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="navbar navbar-inverse  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">StockViz</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-globe"></span>
     
    Macro
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-bnd.html">Fixed Income</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cur.html">Currencies</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cmdy.html">Commodities</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-arrows-v"></span>
     
    52w H&amp;L
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-rocket"></span>
     
    ATH
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-magnet"></span>
     
    Drawdowns
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-train"></span>
     
    Streaks
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-hand-pointer-o"></span>
     
    Indian Indices
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-risk.html">Performance Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-IN.html">Index Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-MKT-CAP.html">Classification Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-industry.html">Industry Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-syn.html">Synthetic Indices</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-vol-NIFTY.html">NIFTY Volatility</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-valuations.html">Valuations</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/results-IN.html">Result Dates</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/eq-in/rp-margin.html">Margin Report</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-shopping-bag"></span>
     
    Funds
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports03/mf/rp-IN.html">Indian Mutual Funds</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports03/pms/rp-IN.html">Indian PMS</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-risk.html">US ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-sector.html">US Sector ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-country.html">Country $ ETFs</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-percent"></span>
     
    Fama-French
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-industry.html">Industry</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-factors.html">Factors</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-regression.html">Regressions</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://stockviz.biz">
    <span class="fa fa-home"></span>
     
  </a>
</li>
<li>
  <a href="https://stockviz.substack.com">
    <span class="fa fa-envelope-o"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">IKS</h1>
<h3 class="subtitle">Equity Metrics</h3>
<h4 class="date">February 13, 2026</h4>

</div>


<div id="inventurus-knowledge-solutions-limited" class="section level1">
<h1>Inventurus Knowledge Solutions Limited</h1>
<p><a href="/reports01/index/industry/rp-ITEnabledServices.html">IT Enabled Services</a></p>
<div id="annual-returns" class="section level2">
<h2>Annual Returns</h2>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IKS.fan.png" /></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IKS.annret.png" /></p>
</div>
<div id="cumulative-returns-and-drawdowns" class="section level2">
<h2>Cumulative Returns and Drawdowns</h2>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IKS.cumret.png" /></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IKS.sma.cumret.png" /></p>
<p><br><br></p>
</div>
<div id="fundamentals" class="section level2">
<h2>Fundamentals</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IKS.eps.png" /></p>
<p><br><br></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IKS.RevenueFromOperations.png" /></p>
<p><br><br></p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IKS.ebit.png" /></p>
<p><br><br></p>
</div>
<div id="ownership" class="section level2">
<h2>Ownership</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IKS.ownership.png" /></p>
<p><br><br></p>
</div>
<div id="margined" class="section level2">
<h2>Margined</h2>
<p><br />
</p>
<p><img src="https://etf-us-risk-plots.stockviz.biz/in.IKS.mtf.png" /></p>
<p><br><br></p>
<p><br />
</p>
</div>
<div id="ai-summary" class="section level2">
<h2>AI Summary</h2>
<p><em>asof: 2025-12-03 </em></p>
<div id="summary-analysis-for-inventurus-knowledge-solutions-limited-iks-health-nse-iks-bse-544309" class="section level9">
<p class="heading">Summary Analysis for Inventurus Knowledge Solutions Limited (IKS Health, NSE: IKS, BSE: 544309)</p>
<p>IKS Health is a leading provider of AI-native care enablement platforms for US healthcare providers, focusing on Revenue Cycle Management (RCM), clinical documentation, coding, prior authorizations, and value-based care. It operates in a ~US$5tn Total Addressable Market (TAM), with strong Q2 FY26 results (ended Sep 30, 2025): Revenue INR 7,811 Mn (+22% YoY INR / +17% USD), EBITDA margin 35% (+530 bps YoY), PAT margin 23% (+560 bps), and robust cash flows (FCF yield 124%). Decade-long CAGR: Revenue 28%, PAT 32%. Below is a structured analysis of <strong>tailwinds</strong>, <strong>headwinds</strong>, <strong>growth prospects</strong>, and <strong>key risks</strong> based on the provided filings (Q2 results, investor presentation, subsidiary investment, AGM voting, office expansion, and investor meet notice).</p>
<div id="tailwinds-positive-catalysts" class="section level12">
<p class="heading"><strong>Tailwinds (Positive Catalysts)</strong></p>
<ul>
<li><strong>Robust Financial Momentum</strong>: Consistent profitable growth with margin expansion (EBITDA 35%, ROE ~32%, EPS INR 10.8 in Q2). Net debt reduced to INR 4.1 Bn (from INR 8.5 Bn YoY), targeting debt-free by FY27. Strong cash generation (OCF INR 3.98 Bn) funds organic growth/R&amp;D.</li>
<li><strong>AI &amp; Technology Leadership</strong>: Agentic AI platform (e.g., Scribble, Autonomous Coding) on Google Cloud; integrations with Epic. #1 rankings (Black Book for AI-RCM/Coding, KLAS for documentation); Google DORA Award 2025. R&amp;D spend up 49% YoY to 4.7% of revenue.</li>
<li><strong>Client Stickiness &amp; Wins</strong>: 640+ clients (85% repeat revenue), top-10 clients average 5.9-year vintage (45% revenue). New marquee deals (AdventHealth expansion to VBC, RevereHealth, cardiology group); 6 cross-sell deals.</li>
<li><strong>Talent &amp; Expansion</strong>: 12,940 employees (17% clinical/tech-focused, 45% women); new 1,000-seat Coimbatore office for US market scaling. Headcount -4% YoY vs. +17% revenue (tech leverage).</li>
<li><strong>Outcome-Based Model</strong>: Revenue tied to client outcomes (e.g., EBITDA uplift), aligning incentives; AI as tailwind for co-monetization.</li>
<li><strong>Macro Tailwinds</strong>: US healthcare spend US$260 Bn (+CAGR via outsourcing market to 2028E); partnerships (Google Cloud, Epic).</li>
</ul>
</div>
<div id="headwinds-challenges" class="section level12">
<p class="heading"><strong>Headwinds (Challenges)</strong></p>
<ul>
<li><strong>Forex Volatility</strong>: Q2 forex gain INR 177 Mn offset by hedges; net +INR 70-80 Mn impact. 50-60% exposure hedged, but USD/INR swings pressure USD revenue growth (17% vs. 22% INR).</li>
<li><strong>Client Concentration</strong>: Top-10 clients = 45% revenue; top-5 = 34%. Vulnerable to churn/loss.</li>
<li><strong>Margin Pressures from Scaling</strong>: Employee costs up 11% YoY (INR 4 Bn in Q2); upfront guarantees in outcome deals (e.g., Palomar NEVA recoverability in 3-4 years).</li>
<li>** moderated Headcount Growth**: -4% YoY despite ramps; slower than revenue to leverage AI, but risks execution delays.</li>
<li><strong>Post-IPO Scrutiny</strong>: Recent listing (Dec 2024); some AGM dissent (e.g., 6-45% against certain director appointments/resolutions like ESOP amendments).</li>
</ul>
</div>
<div id="growth-prospects-high-potential" class="section level12">
<p class="heading"><strong>Growth Prospects (High Potential)</strong></p>
<ul>
<li><strong>Near-Term (FY26-FY27)</strong>: 20%+ revenue growth via platform adoption, cross-sell (e.g., AQuity integration yielding margin gains), new wins in health systems/physician groups. H1 FY26: +19% YoY revenue.</li>
<li><strong>Medium-Term</strong>: AI expansion across patient journey (pre/visit/post-care, in-acute); outcome deals unlocking “second economic pool” (EBITDA share). Subsidiary investments (e.g., USD 10 Mn in IKS Inc., associate stake).</li>
<li><strong>Long-Term</strong>: TAM CAGR (outsourced RCM/VBC); leadership in agentic AI (#1 rankings); global diversification (India ops, US focus). Analyst meets (Nov 21, 2025) signal investor engagement. FCF supports tuck-in M&amp;A/debt paydown.</li>
<li><strong>Projections</strong>: Sustained 20-25% growth, EBITDA margins 34-36%, ROE &gt;30%; debt-free FY27 enables dividends/buybacks.</li>
</ul>
<table>
<thead>
<tr class="header">
<th>Metric</th>
<th>Q2 FY26</th>
<th>YoY Growth</th>
<th>Margin</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td>Revenue (INR Mn)</td>
<td>7,811</td>
<td>+22%</td>
<td>-</td>
</tr>
<tr class="even">
<td>EBITDA</td>
<td>2,718</td>
<td>+43%</td>
<td>35%</td>
</tr>
<tr class="odd">
<td>PAT</td>
<td>1,807</td>
<td>+60%</td>
<td>23%</td>
</tr>
<tr class="even">
<td>EPS (INR)</td>
<td>10.8</td>
<td>+59%</td>
<td>-</td>
</tr>
</tbody>
</table>
</div>
<div id="key-risks-moderate-high-mitigated-by-track-record" class="section level12">
<p class="heading"><strong>Key Risks (Moderate-High, Mitigated by Track Record)</strong></p>
<table>
<colgroup>
<col width="37%" />
<col width="32%" />
<col width="30%" />
</colgroup>
<thead>
<tr class="header">
<th>Risk Category</th>
<th>Description</th>
<th>Mitigation</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td><strong>Execution/Integration</strong></td>
<td>AQuity integration delays; AI outcome delivery (e.g., Palomar recoverability).</td>
<td>Proven track record (10-yr growth); cross-sell success.</td>
</tr>
<tr class="even">
<td><strong>Forex &amp; Macro</strong></td>
<td>USD depreciation; US healthcare policy/recession.</td>
<td>50-60% hedges; USD revenue 100% hedged effectively.</td>
</tr>
<tr class="odd">
<td><strong>Concentration</strong></td>
<td>Top clients 45%; US-centric (forex/regulatory).</td>
<td>Long vintages (5-7 yrs); repeat 85%; India talent diversification.</td>
</tr>
<tr class="even">
<td><strong>Competition</strong></td>
<td>RCM/AI peers (e.g., Change Healthcare).</td>
<td>Differentiated outcome model; awards/partnerships.</td>
</tr>
<tr class="odd">
<td><strong>Regulatory/Compliance</strong></td>
<td>US HIPAA, SEBI LODR; ESOP dilution (recent grants).</td>
<td>Strong governance (AGM resolutions passed); audited results.</td>
</tr>
<tr class="even">
<td><strong>Operational</strong></td>
<td>Talent ramp in new office; capex (intangibles up).</td>
<td>Tech leverage (revenue/employee INR 0.91 Mn annualized).</td>
</tr>
<tr class="odd">
<td><strong>Financial</strong></td>
<td>Borrowings INR 6.4 Bn; forex gains one-off.</td>
<td>Strong FCF (124% yield); debt reduction trajectory.</td>
</tr>
</tbody>
</table>
<p><strong>Overall Outlook</strong>: <strong>Strong Buy/Bullish</strong>. Tailwinds from AI/platform dominance and financial strength outweigh headwinds. Growth prospects remain robust (20%+ CAGR) in expanding US healthcare outsourcing, with risks well-managed via cash buffers and outcome alignment. Monitor forex, client wins, and Q3 execution. Valuation likely supported by 35% margins and 32% ROE in high-TAM sector.</p>
</div>
</div>
</div>
</div>

&nbsp;
&nbsp;
<hr />
<p style="text-align: center;">Copyright &copy; 2023 SAS Data Analytics Pvt. Ltd. All rights reserved.</p>
<p style="text-align: center;"><a href="https://github.com/stockviz/reports/issues">&#x1F41E;</a></p>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
